OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Low HER2 expression in normal breast epithelium enables dedifferentiation and malignant transformation via chromatin opening
Ateequllah Hayat, Edward Carter, Hamish W. King, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 8
Ateequllah Hayat, Edward Carter, Hamish W. King, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 8
Showing 8 citing articles:
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
Mariia Ivanova, Francesca Porta, Marianna D’Ercole, et al.
Virchows Archiv (2023) Vol. 484, Iss. 1, pp. 3-14
Open Access | Times Cited: 38
Mariia Ivanova, Francesca Porta, Marianna D’Ercole, et al.
Virchows Archiv (2023) Vol. 484, Iss. 1, pp. 3-14
Open Access | Times Cited: 38
Identification of mammalian transcription factors that bind to inaccessible chromatin
Romana T. Pop, Alessandra Pisante, Dorka Nagy, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 16, pp. 8480-8495
Open Access | Times Cited: 18
Romana T. Pop, Alessandra Pisante, Dorka Nagy, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 16, pp. 8480-8495
Open Access | Times Cited: 18
Tyr352 as a Predominant Phosphosite in the Understudied Kinase and Molecular Target, HIPK1: Implications for Cancer Therapy
Diya Sanjeev, Mejo George, Levin John, et al.
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 3, pp. 111-124
Closed Access | Times Cited: 3
Diya Sanjeev, Mejo George, Levin John, et al.
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 3, pp. 111-124
Closed Access | Times Cited: 3
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Sara Spaziani, Alessandro Esposito, Giovannina Barisciano, et al.
Research Square (Research Square) (2024)
Open Access
Sara Spaziani, Alessandro Esposito, Giovannina Barisciano, et al.
Research Square (Research Square) (2024)
Open Access
Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines
Sara Spaziani, Alessandro Esposito, Giovannina Barisciano, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
Sara Spaziani, Alessandro Esposito, Giovannina Barisciano, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
Pathological precision diagnosis and recent advances in HER2 low and ultralow in breast cancer: a narrative review
Jiuyan Shang, Yueping Liu
Translational Breast Cancer Research (2024) Vol. 5, pp. 29-29
Closed Access
Jiuyan Shang, Yueping Liu
Translational Breast Cancer Research (2024) Vol. 5, pp. 29-29
Closed Access
Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer
J Steggall, Vinothini Rajeeve, Najah Alsubaie, et al.
(2024)
Open Access
J Steggall, Vinothini Rajeeve, Najah Alsubaie, et al.
(2024)
Open Access
